With new medications extending the lives of advanced cancer patients, many live for years in the face of radical uncertainty. A new CU Boulder-born therapy has been shown to reduce trauma, depression, anxiety and fear.
On the eve of the 25th remembrance of the Columbine High School shooting, the director of CU’s Center for the Study and Prevention of Violence reflects on what we’ve learned and what we can do better to stem the nation’s tide of mass shootings.
Four years after the U.S. began to slowly emerge from mandatory COVID-19 lockdowns, a study of 7,000 aging adults suggests that for many, life has never been the same.
A new CU Boulder study sheds light on how genes associated with smoking work in conjunction with the rest of the genome, paving the way for more personalized approaches to help people kick the habit.
The first randomized trial to examine how commercially available cannabis impacts anxiety symptoms has shown that products heavy in the nonintoxicating compound CBD work surprisingly well—and without getting you high.
Increased access to prescription opioids and a shrinking economic safety net contributed to an increase in suicide rates in the 21st century, according to new CU Boulder research.
The brain produces more of the pleasure-inducing hormone dopamine when we’re longing for or hanging out with our partner, according to research by CU Boulder neuroscientists. But when we break up, that unique “chemical imprint” fades away.
A first-of-a-kind laboratory study of runners shows that using cannabis before training can boost motivation and mood. However, if the THC content is high, it can also make exercise feel harder, potentially sabotaging performance.
A new study of compounds found in baby poop suggests breast milk, including milk supplemented with formula, improves infant gut health in ways that benefit brain development and could impact test scores. The findings could also be used to improve formula.